ATNM - Actinium Pharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-0.04-0.04-0.18-0.09
Low Estimate-0.05-0.05-0.21-0.14
High Estimate-0.04-0.04-0.16-0.05
Year Ago EPS-0.04-0.06-0.22-0.18
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. EstimateN/AN/AN/A23.9M
Low EstimateN/AN/AN/A19.04M
High EstimateN/AN/AN/A28.76M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.07-0.05-0.05-0.06
EPS Actual-0.04-0.06-0.05-0.05
Difference0.03-0.0100.01
Surprise %42.90%-20.00%0.00%16.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.04-0.04-0.18-0.09
7 Days Ago-0.04-0.04-0.18-0.07
30 Days Ago-0.04-0.04-0.18-0.07
60 Days Ago-0.06-0.06-0.19-0.07
90 Days Ago-0.06-0.06-0.19-0.07
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesATNMIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.01
Next Qtr.33.30%N/AN/A0.03
Current Year18.20%N/AN/A0.04
Next Year50.00%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A